Tag: IMTECH
CSIR’s new clot buster, PEGylated Streptokinase holds great promise for brain...
Developed by the Chandigarh based CSIR-IMTECH, the patented PEGylated Streptokinase for treatment of Ischemic Stroke will be further developed and marketed by Epygen Biotech, Mumbai under an exclusive agreement……………….
Zydus Cadila & IMTECH to jointly identify new drugs to tackle...
The research partnership between Zydus Cadilla and Institute of Microbial Technology, will primarily aim to identify new drug candidates for treatment of drug-resistant infections...……….
Scientist uncover a piece in the puzzle of macrophage activation
Scientists at the Institute of Microbial Technology (IMTECH), Chandigarh have found that a protein called Arf-like (Arl) GTPase-11(Arl11) activates macrophages in response to pathogenic stimuli...........
Dr Javed Agrewala of IIT-R awarded ‘JC Bose Fellowship’ for TB...
Dr Agrewala has developed a chimeric vaccine by carefully studying the snags associated with BCG failure to protect public living in TB-endemic regions..................
Johnson & Johnson partners CSIR-IMTECH to develop new TB drugs
Memorandum of Understanding brings together best scientists from India and Johnson & Johnson to increase level and accelerate pace of innovation needed to make Tuberculosis history.......